PHAT
Phathom Pharmaceuticals Inc
NASDAQ · Pharmaceuticals
$12.58
+0.17 (+1.37%)
Open$12.82
Previous Close$12.41
Day High$12.94
Day Low$12.20
52W High$18.31
52W Low$2.21
Volume—
Avg Volume847.6K
Market Cap984.95M
P/E Ratio—
EPS$-3.81
SectorPharmaceuticals
Analyst Ratings
Strong Buy
16 analysts
Price Target
+303.3% upside
Current
$12.58
$12.58
Target
$50.74
$50.74
$34.41
$50.74 avg
$70.04
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 68.48M | 173.93M | 162.51M |
| Net Income | -414,335,962 | 52.15M | 46.06M |
| Profit Margin | -605.1% | 30.0% | 28.4% |
| EBITDA | -342,891,977 | 99.13M | 88.44M |
| Free Cash Flow | — | 45.89M | 35.44M |
| Rev Growth | — | -4.6% | -5.1% |
| Debt/Equity | 1.24 | 0.67 | 0.68 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |